TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT01921985

Terlipressin Administration in Patients Undergoing Major Liver Resection

Cause of deathFutility Automatic label, confidence 0.9, unverified. How labels are made.
“Interim analysis revealed that no statistical difference will be identified after inclusion of the patient cohort as foreseen in the sample size calculation”

The sponsor’s own words in the registry.

Life of this trial

2013201420152016201720182019Registered2013-08-09Started2013-11Stopped2018-03

Vital statistics

Status
Terminated
Phase
Phase 2
Sponsor
Insel Gruppe AG, University Hospital Bern
Sponsor type
University, hospital or other
Conditions
Liver Resection; Liver Failure
Interventions
Terlipressin; Placebo
Participants
150
Sites
1
Countries
Switzerland

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.